The primary objective is to evaluate the feasibility and adherence of 6 weeks of rehabilitation with the SEA in participants who underwent TL. The secondary objective is to examine if the SEA is an effective tool to improve swallowing function and…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Hoofdhalskankerpatienten die een totale laryngectomie hebben ondergaan
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
This study has a multidimensional assessment approach, including feasibility
and adherence, physical outcomes, functional outcomes, and patient-reported
outcomes. In this study, measures of interest are muscle strength,
manofluorography, manometry, voice recordings, dynamic range of voice, maximum
fonation time, questionnaires, and information from the electronic medical
files.
Secondary outcome
Secondary: (Multidimensional Evaluation)
Physical outcomes:
- Strength measurement (IOPI, dynamometer)
- Manofluorography
- Pressure measurement during breathing and vocalization (manometry)
Functional Outcomes:
- Voice recordings
- Mouth opening
Subjective outcomes:
- Questionnaires on Quality of life, swallowing problems, voice problems,
participation
Background summary
Total laryngectomy (TL), implicating surgical removal of the larynx, is the
operation of choice in patients with advanced laryngeal or hypopharyngeal
cancer. Functional disabilities associated with TL include impairment of
swallowing, speech, olfaction, and taste. Muscle strength, muscle coordination,
and pressure build-up are essential factors for swallowing and
tracheoesophageal speech. Research has shown that TL negatively influences the
patients* pressure build-up at the base of the tongue and coordination of
muscular contraction in the neopharynx. The Swallow Exercise Aid (SEA) is
developed as an exercise tool that activates and strengthens the suprahyoid and
pharyngeal muscles relevant for swallowing function. The feasibility and
adherence were considered good in healthy senior adults and head and neck
cancer patients with chronic dysphagia. Following these positive results, the
feasibility, adherence, and effectiveness of its use for rehabilitation of
swallowing and tracheoesophageal speech will be studied in patients with
altered anatomy because of TL.
Study objective
The primary objective is to evaluate the feasibility and adherence of 6 weeks
of rehabilitation with the SEA in participants who underwent TL. The secondary
objective is to examine if the SEA is an effective tool to improve swallowing
function and tracheoesophageal speech. The outcomes include functional
(swallowing efficiency, vocal functioning) and physical (intra-pharyngeal
pressure) outcomes, patient-reported complaints, and quality of life.
Study design
The proposed study is a pilot study and includes a prospective feasibility
study involving one training group, six weeks of training and three moments of
assessment.
Intervention
All participants have to train three different strengthening exercises with the
SEA three times a day, including the Chin Tuck against resistance (CTAR+), Jaw
Opening against resistance (JOAR+), and the Effortful swallow exercise (ES+)
for six weeks.
Study burden and risks
Participating in this study and training with the SEA might improve swallowing
function and voice quality. These improvements may lead to enhance the quality
of life. Muscular pain or muscular exhaustion might be the only risk associated
with participation in this study. The assessments contain radiation and
manometry in which nose bleeding is a minimal risk.
Plesmanlaan 121
Amsterdam 1066CX
NL
Plesmanlaan 121
Amsterdam 1066CX
NL
Listed location countries
Age
Inclusion criteria
• >= 18 years or older
• Undergone a TLE
• At least six months post TLE
• At least six months postoperative (chemo-) radiotherapy (if applicable)
• Using Tracheoesophageal speech
• Oral intake of a modified diet (FOIS 2 - 6) or who experience swallowing
problems
• Signed informed consent
Exclusion criteria
• Unable to understand the patient information
• Unable to understand the informed consent
• Unable to comprehend and use the SEA
• Unable or unwilling to provide informed consent
• Neuro-degenerative diseases, for instance, dementia, Parkinson, Korsakov
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL78528.031.21 |